Brokerages Set Avantor, Inc. (NYSE:AVTR) PT at $11.83

Shares of Avantor, Inc. (NYSE:AVTR) have received an average rating of “Hold” from the sixteen brokerages that are currently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and three have issued a buy rating on the company. The average 1 year price target among analysts that have covered the stock in the last year is $11.8333.

A number of equities analysts have recently commented on the company. Citigroup dropped their price objective on Avantor from $13.00 to $11.00 and set a “neutral” rating on the stock in a research note on Thursday, February 12th. Raymond James Financial lowered Avantor from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 4th. Wells Fargo & Company dropped their price target on Avantor from $16.00 to $14.00 and set an “overweight” rating on the stock in a research report on Friday, February 13th. UBS Group reiterated a “neutral” rating and set a $10.50 price target on shares of Avantor in a report on Thursday, February 12th. Finally, Zacks Research downgraded shares of Avantor from a “hold” rating to a “strong sell” rating in a research note on Friday, February 13th.

Insiders Place Their Bets

In related news, Director Gregory L. Summe purchased 100,000 shares of the firm’s stock in a transaction on Thursday, February 12th. The shares were bought at an average cost of $9.40 per share, for a total transaction of $940,000.00. Following the transaction, the director directly owned 400,000 shares of the company’s stock, valued at approximately $3,760,000. This trade represents a 33.33% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Sanjeev K. Mehra acquired 350,000 shares of the business’s stock in a transaction dated Friday, December 5th. The shares were bought at an average cost of $11.09 per share, with a total value of $3,881,500.00. Following the transaction, the director directly owned 350,000 shares of the company’s stock, valued at $3,881,500. The trade was a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased 500,000 shares of company stock worth $5,279,500 in the last ninety days. Insiders own 1.20% of the company’s stock.

Institutional Trading of Avantor

A number of hedge funds have recently modified their holdings of the company. TD Private Client Wealth LLC increased its position in shares of Avantor by 9.2% during the third quarter. TD Private Client Wealth LLC now owns 7,985 shares of the company’s stock valued at $100,000 after purchasing an additional 670 shares during the period. Private Trust Co. NA increased its holdings in Avantor by 46.2% in the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after buying an additional 875 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Avantor by 28.1% in the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock valued at $49,000 after buying an additional 905 shares in the last quarter. TD Waterhouse Canada Inc. lifted its holdings in shares of Avantor by 2.5% during the 3rd quarter. TD Waterhouse Canada Inc. now owns 38,977 shares of the company’s stock worth $532,000 after acquiring an additional 966 shares during the period. Finally, SG Americas Securities LLC boosted its position in shares of Avantor by 2.7% during the 2nd quarter. SG Americas Securities LLC now owns 37,078 shares of the company’s stock valued at $499,000 after acquiring an additional 979 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.

Avantor Trading Down 0.4%

NYSE:AVTR opened at $9.02 on Tuesday. The company’s 50 day moving average is $11.02 and its 200-day moving average is $12.03. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. Avantor has a 12 month low of $8.80 and a 12 month high of $18.02. The firm has a market cap of $6.15 billion, a price-to-earnings ratio of -11.56, a P/E/G ratio of 3.57 and a beta of 0.94.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.01. The business had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.64 billion. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. Avantor’s quarterly revenue was down 1.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.27 EPS. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. Equities analysts anticipate that Avantor will post 1.06 EPS for the current year.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.